FDA approves methotrexate, an anti-metabolite derived from folic acid, and 6-mercaptopurine as anti-cancer drugs.
FDA approves methotrexate, an anti-metabolite derived from folic acid, and 6-mercaptopurine as anti-cancer drugs.
FDA批准叶酸衍化的抗代谢药甲氨蝶呤和6-巯基嘌呤作为抗癌药物.